MwanzoMANKIND • NSE
add
Mankind Pharma Ltd
Bei iliyotangulia
₹ 2,477.45
Bei za siku
₹ 2,460.65 - ₹ 2,534.10
Bei za mwaka
₹ 1,901.05 - ₹ 3,054.80
Thamani ya kampuni katika soko
1.03T INR
Wastani wa hisa zilizouzwa
elfu 654.81
Uwiano wa bei na mapato
47.06
Mgao wa faida
-
Ubadilishanaji wa msingi
NSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 32.30B | 23.90% |
Matumizi ya uendeshaji wa biashara | 16.57B | 29.21% |
Mapato halisi | 3.80B | -16.20% |
Kiwango cha faida halisi | 11.77 | -32.40% |
Mapato kwa kila hisa | 9.44 | -16.53% |
EBITDA | 7.34B | 27.38% |
Asilimia ya kodi ya mapato | 22.68% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 47.27B | 103.22% |
Jumla ya mali | — | — |
Jumla ya dhima | — | — |
Jumla ya hisa | 107.89B | — |
hisa zilizosalia | 402.36M | — |
Uwiano wa bei na thamani | 9.39 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 14.14% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 3.80B | -16.20% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1991
Tovuti
Wafanyakazi
19,540
